EBERS Solutions specializes in statistical programming, data management, and biostatistics, delivering high-quality services to enhance clinical research and optimize data integrity. Our customized solutions ensure accuracy, efficiency, and full regulatory compliance at every stage of the clinical trial process.
Delivering high-quality, reliable data solutions with a focus on precision and accuracy.
Offering Customized services designed to meet the unique needs of your clinical trials and therapeutic areas.
Streamlining complex processes through automation, enhancing efficiency, and reducing time-to-insight.
Ensuring all solutions adhere to the highest industry standards and regulatory requirements.
Transforming complex data into clear, actionable insights that empower informed decision-making.
• Analyzing dose-escalation studies, including advanced methods like the Continual Reassessment Method (CRM).
• Rapid reporting of adverse events (AEs) and pharmacokinetic (PK) data
• Analyzing progression-free survival (PFS) and objective response rate (ORR) with advanced statistical models.
• Managing multi-center, global trials with standardized data collection and quality assurance.
• Conducting interim analyses and preparing data for Data Safety Monitoring Boards (DSMBs).
• Monitoring hemodynamic parameters such as blood pressure, heart rate, and ECG data.
• Rapid identification and reporting of adverse events (AEs) related to cardiovascular endpoints.
• Ensuring robust data management for long-term follow-ups in chronic conditions like heart failure or hypertension.
• Analyzing cardiovascular endpoints, such as left ventricular ejection fraction (LVEF) and myocardial infarction incidence.
• Analyzing trials for ophthalmic solutions, including topical, injectable, and implantable treatments.
• Handling datasets from combination therapies, often used in ophthalmology.
• Capturing adverse events specific to ophthalmology, such as ocular inflammation or intraocular pressure changes.
• Data management for endpoints like forced expiratory volume (FEV1) and symptom score reductions.
• Statistical analyses of inflammatory markers and biomarker-driven therapies.
• Handling primary and secondary endpoints such as exacerbation frequency and lung function preservation.
• Analyzing endpoints such as cognitive function scores, motor ability assessments, and disease progression scales
• Managing data from complex adaptive trial designs.
• Analyzing long-term progression data for chronic conditions.
• Expertise in managing ultra-rare populations with small sample sizes.
• Developing innovative statistical approaches to maximize data insights.
• Designing observational studies to build robust natural history data.